Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer

Experimental and Toxicologic Pathology

Volumn 56, Issue 4-5, 2005, Pages 255-263

  Green, Andrew R ^a   Styles, Jerry A ^a   Parrott, Emma L ^a   Gray, Douglas ^a   Edwards, Richard E ^a   Smith, Andrew G ^a   Gant, Timothy W ^a   Greaves, Peter ^a   Al Azzawi, Farook ^a   White, Ian N H ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Adenomyosis; Gene arrays; Mice; Tamoxifen; Uterus

Indexed keywords

COLLAGEN; ESTROGEN; RNA; TAMOXIFEN; XENOBIOTIC AGENT;

ADENOMYOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM; FEMALE; GENE EXPRESSION; INCIDENCE; LIPID STORAGE; LONG TERM EXPOSURE; MOUSE; MYOMETRIUM; NEWBORN; NONHUMAN; PATHOLOGY; PRECANCER; PROTEIN FUNCTION; SMOOTH MUSCLE; STROMA; UPREGULATION; UTERUS; UTERUS CANCER;

EID: 20044389666     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2004.10.001     Document Type: Article

References (34)

1. V. Anaf, P. Simon, and N.I. El Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis Hum Reprod 17 2002 1895 1900
2. Anonymous. Some pharmaceutical drugs. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 66. 1996. p. 253-365
3. D.E. Bjorling, M. Beckman, and M.K. Clayton Modulation of nerve growth factor in peripheral organs by estrogen and progesterone Neuroscience 110 2002 155 167
4. V. Bourdeau, J. Deschenes, and R. Metivier Genome-wide identification of high-affinity estrogen response elements in human and mouse Mol Endocrinol 18 2004 1411 1427
5. P.H. Brown, and S.M. Lippman Chemoprevention of breast cancer Breast Cancer Res Treat 62 2000 1 17
6. P.L. Carmichael, J.C.M. Pole, and P. Neven Modulation of endometrial transforming growth factor beta (TGF beta) by tamoxifen Eur J Cancer 36 2000 S42 S43
7. P. Carthew, R.E. Edwards, and B.M. Nolan Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia Carcinogenesis 21 2000 793 797
8. 32P-postlabelling in three rat strains exposed to dietary tamoxifen the relationship between cell proliferation and liver tumour formation Carcinogenesis 16 1995 1299 1304
9. W.S. Cleveland Lowess - a program for smoothing scatterplots by robust locally weighted regression Am Stat 35 1981 54
10. I. Cohen, Y. Beyth, and J. Shapira High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifen Gynecol Obstet Invest 44 1997 200 205
11. J.F. Couse, V.L. Davis, and R.B. Hanson Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol Mol Carcinog 19 1997 236 242
12. S. Descamps, R.A. Toillon, and E. Adriaenssens Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways J Biol Chem 276 2001 17864 17870
13. S. Donald, R.D. Verschoyle, and D.J. Judah Hepatobiliary damage and changes in hepatic gene expression caused by the antitumor drug ecteinascidin-743 (ET-743) in the female rat Cancer Res 62 2002 4256 4262
14. A.R. Green, E.L. Parrott, and M. Butterworth Comparisons of the effects of tamoxifen, toremifene and raloxifene on enzyme induction and gene expression in the ovariectomised rat uterus J Endocrinol 170 2001 555 564
15. S.D. Jenson, R.S. Robetorye, and S.D. Bohling Validation of cDNA microarray gene expression data obtained from linearly amplified RNA Mol Pathol 56 2003 307 312
16. M. Kowanetz, U. Valcourt, and R. Bergstrom Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein Mol Cell Biol 24 2004 4241 4254
17. S. Krygier, and D. Djakiew Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells Int J Cancer 98 2002 1 7
18. S. Li, L. Ma, and T. Chiang Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure Mol Carcinog 32 2001 213 219
19. S. Li, K.A. Washburn, and R. Moore Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus Cancer Res 57 1997 4356 4359
20. E.A. Martin, P. Carthew, and I.N.H. White Investigation of the formation and accumulation of liver DNA adducts in mice chronically exposed to tamoxifen Carcinogenesis 18 1997 2209 2215
21. G.L. Mutter, J.P. Baak, and J.T. Fitzgerald Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation Gynecol Oncol 83 2001 177 185
22. R.R. Newbold, E.P. Banks, and B. Bullock Uterine adenocarcinoma in mice treated neonatally with genistein Cancer Res 61 2001 4325 4328
23. R.R. Newbold, B.C. Bullock, and J.A. Mclachlan Uterine adenocarcinoma in mice following developmental treatment with estrogens a model for hormonal carcinogenesis Cancer Res 50 1990 7677 7681
24. R.R. Newbold, W.N. Jefferson, and E. Padilla-Burgos Uterine carcinoma in mice treated neonatally with tamoxifen Carcinogenesis 18 1997 2293 2298
25. R.R. Newbold, and J.G. Liehr Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens Cancer Res 60 2000 235 237
26. E. Parrott, M. Butterworth, and A. Green Adenomyosis - a result of disordered stromal differentiation Am J Pathol 159 2001 623 630
27. G.C. Raju, V. Naraynsingh, and J. Woo Adenomyosis uteri a study of 416 cases Aust N Z J Obstet Gynaecol 28 1988 72 73
28. K. Seidl, C. Erck, and A. Buchberger Evidence for the participation of nerve growth factor and its low-affinity receptor (p75NTR) in the regulation of the myogenic program J Cell Physiol 176 1998 10 21
29. K.D. Setchell, L. Zimmer-Nechemias, and J. Cai Exposure of infants to phyto-oestrogens from soy-based infant formula Lancet 350 1997 23 27
30. T.S. Shields, N.S. Weiss, and L.F. Voigt The additional risk of endometrial cancer associated with unopposed estrogen use in women with other risk factors Epidemiology 10 1999 733 738
31. N.J. Turton, D.J. Judah, and J. Riley Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance Oncogene 20 2001 1300 1306
32. P. Vercellini, F. Parazzini, and S. Oldani Adenomyosis at hysterectomy a study on frequency distribution and patient characteristics Hum Reprod 10 1995 1160 1162
33. B. Vogelstein, and K.W. Kinzler Cancer genes and the pathways they control Nat Med 10 2004 789 799
34. E.T. Walch, and D. Marchetti Role of neurotrophins and neurotrophin receptors in the in vitro invasion and heparanase production of human prostate cancer cells Clin Exp Metastasis 17 1999 307 314